Trademarkia Logo

Canada

C$
NANT CANCER VACCINE
SEARCHED

on 7 Nov 2024

Last Applicant/ Owned by

Nant Holdings IP, LLC

9920 Jefferson Blvd.Culver City CA 90232

US

Serial Number

2274208 filed on 1st Mar 2023

NANT CANCER VACCINE

Trademark usage description

pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer f Read More

Classification Information


Class [005]
Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, in the field of vaccines; low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, cell therapies, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapy, low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, personalized neoepitope-based therapies, cell therapies, and natural killer cell derived preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes featuring cell cultures, reagents and related instructions


Classification kind code

12

Class [042]
Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, and vaccines; product development in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells and cell derived preparations


Classification kind code

12

Class [044]
Medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines biologics, cells and cell-derived preparations; providing information relating to pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells, and cell-derived preparations


Classification kind code

12

Mark Details


Serial Number

2274208

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 7th Nov 2024
Search Recorded
Submitted for opposition 20
on 7th Nov 2024
Examiner's First Report
Submitted for opposition 223
on 7th Nov 2024
Total Provisional Refusal
Submitted for opposition 256
on 10th Jun 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 10th Aug 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 9th Aug 2023
Created
Submitted for opposition 31
on 9th Aug 2023
Formalized
Submitted for opposition 228
on 1st Mar 2023
International Registration
Submitted for opposition 30
on 1st Mar 2023
Filed